Actionable news
0
All posts from Actionable news
Actionable news in MRK: MERCK & CO. Inc,

Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2017-2023 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023" report to their offering.

Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023 report gives comprehensive insight on various clinical and non-clinical advancements in the global dendritic cell cancer vaccine market.

In recent years, dendritic cell cancer vaccines have emerged as new growth frontier for the companies involved in the research and development of drugs for the treatment of cancer. As per report findings, currently there are 53 dendritic cell cancer vaccines in clinical pipeline. Most of the dendritic cell cancer vaccines are in preclinical phase followed by phase-II clinical trials.

Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023 Highlights:

- Global Dendritic Cell Cancer Vaccine Market Overview

- Assessment of Dendritic Vaccines with Other Therapeutic Regimens

- Global Dendritic Cell Vaccines Clinical Pipeline by Company, Indication & Phase

- Marketed Dendritic Cell Vaccines Clinical Insight

- Dendritic Cells Mechanizing Immune...


More